Added to YB: 2025-12-10
Pitch date: 2025-12-05
HIMS [neutral]
Hims & Hers Health, Inc.
-5.41%
current return
Author Info
No bio for this author
Company Info
Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, and internationally.
Market Cap
$8.9B
Pitch Price
$39.34
Price Target
N/A
Dividend
N/A
EV/EBITDA
52.94
P/E
73.02
EV/Sales
4.26
Sector
Health Care Providers and Services
Category
growth
Big news: Hims & Hers acquires YourBio Health, approves a share buyback program and enters into the Canadian market.
HIMS (update): Acquired YourBio's painless microneedle blood collection tech (TAP/HALO devices) for home diagnostics integration, closing early 2026. Enables at-home blood tests up to 900µL volume, removing needle phobia barriers. $250M buyback approved. Launched in Canada via Livewell acquisition. Blood testing market $104B growing to $212-250B by 2032-35.
Read full article (5 min)